Transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection(PEI) in the treatment of primary hepatocellular carcinoma(HCC)
Changsheng Wang
Abstract
Changsheng Wang
Abstract
【Objective】 To explore the clinical effect of transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection(PEI) in the treatment of primary hepatocellular carcinoma(HCC).【Methods】 36 patients with primary HCC were randomly divided into A and B groups.Group A including 18 patients were treated with TACE,and after a week,they were treated with PEI.Group B including 18 patients were only treated with TACE.【Results】 The decrease of AFP and shrinkage of tumor mass in group A were 72.2%(13/18),61.1%(11/18),while those of group B were 38.8%(7/18),33.3%(6/18),respectively.The survival rates of 1 and 2 years in group A were 72.2%(13/18),38.8%(7/18),and those of group B were 50%(9/18),16.7%(3/19),respectively.There were significant differences between the two groups.P 0.05.【Conclusions】 The curative effect of TACE and PEI is superior to only TACE for 36 patients with primary HCC.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
【Objective】 To explore the clinical effect of transcatheter arterial chemoembolization(TACE) combined with percutaneous ethanol injection(PEI) in the treatment of primary hepatocellular carcinoma(HCC).【Methods】 36 patients with primary HCC were randomly divided into A and B groups.Group A including 18 patients were treated with TACE,and after a week,they were treated with PEI.Group B including 18 patients were only treated with TACE.【Results】 The decrease of AFP and shrinkage of tumor mass in group A were 72.2%(13/18),61.1%(11/18),while those of group B were 38.8%(7/18),33.3%(6/18),respectively.The survival rates of 1 and 2 years in group A were 72.2%(13/18),38.8%(7/18),and those of group B were 50%(9/18),16.7%(3/19),respectively.There were significant differences between the two groups.P 0.05.【Conclusions】 The curative effect of TACE and PEI is superior to only TACE for 36 patients with primary HCC.
Key concepts: Percutaneous ethanol injection, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Medicine, Gastroenterology, Internal medicine, Group B, Percutaneous